Patient question guide · Published 2026-10-20

Warts Keep Returning After Cryotherapy—Do I Need Immune Testing?

A wart returning after freezing does not by itself diagnose an immune disorder or mean everyone needs immune testing. Discuss further assessment when extensive, persistent lesions occur alongside other recurrent infections, immunosuppressive medicines or a relevant family history.

“My hand and foot warts return after several freezing sessions. Is my immune system weak, and do I need tests?”

Repeat sessions are not an immune diagnosis

The AAD says freezing often needs more than one session, commonly repeated every two to four weeks. The Japanese Dermatological Association also explains that no single method works best for everyone. First distinguish a lesion that never cleared, one that reappeared at the treated site and new lesions elsewhere. A session count alone does not establish poor treatment or immune disease.

[1] American Academy of Dermatology. Warts: diagnosis and treatment [3] 日本皮膚科学会. いぼの治療 Q6 — patient guidance

History can identify reasons to investigate

Zampella and Cohen's 2022 literature review proposes considering other recurrent infections, frequent antibiotic use since childhood, autoimmune disease and family history of immunodeficiency in severe, recurrent or recalcitrant warts. This is an assessment proposal based on literature and experience, not a diagnostic rule or evidence that all recurrent warts indicate immune deficiency. Tests are chosen after history and examination.

[2] Zampella J, Cohen B. Skin Health Dis. 2022;2:e98. Literature review; DOI 10.1002/ski2.98

Bomyung: specify the review, not a vague immune boost

Near Gangnam Station, Seok-Yong Jo, PhD in Korean Medicine, draws on 24 years focused on wart care to review prior records and the current lesion. The review separates distribution, duration, periods of apparent clearance, new lesions, other infections and medicines. Dermatology or other medical assessment may come first when needed. If Korean medicine is suitable, an individual plan may include prescribed Bomyunghwan or Bomyungtang and selected in-clinic care such as pharmacopuncture. This does not replace investigation of immune disease or management of existing prescriptions.

What herbal research does and does not show

A 2021 Korean report followed one six-year-old with hand warts receiving herbal medicine, using photographs and measurements. It had no comparison group and further efficacy and safety research is needed. Its prescription cannot be assumed equivalent to Bomyunghwan or Bomyungtang. It does not demonstrate immune normalisation, HPV eradication, prevention of recurrence or Bomyung's effectiveness.

[4] Kim JH et al. J Korean Med Ophthalmol Otolaryngol Dermatol. 2021;34(4):154–163. Single case; DOI 10.6114/jkood.2021.34.4.154

Prepare history before buying tests

Do not buy an immune test package or stop prescribed immunosuppressants yourself. Review these records with the treating clinician before deciding on investigations.

Dates, methods and session counts; persistence versus intervals after apparent clearance
Locations, changes in lesion number and dated photographs
Other recurring infections and antibiotic history
Autoimmune conditions, immunosuppressive treatment, family history, medicines and allergies

Questions before your visit

Can one immune number explain my warts?

No single general 'immunity' value explains every case. History and examination guide which tests, if any, are relevant.

Should I simply continue freezing?

Review diagnosis, change, skin healing and treatment burden rather than counting sessions alone. Decide stopping or combining care with clinicians.

Can herbs prevent recurrence without an assessment?

That cannot be promised. Herbal care does not replace necessary medical evaluation, and interactions and adverse effects need consideration.

Sources and limits

Patient guidance, a review proposing assessment and an uncontrolled single-child case are different evidence types. None supplies a general immune-disease rate among patients with recurrent warts or a Bomyung success rate.